• Patent Title: System for optimizing a patient's drug dosage regimen over time
  • Application No.: US14008911
    Application Date: 2012-03-29
  • Publication No.: US09619625B2
    Publication Date: 2017-04-11
  • Inventor: Henrik Bengtsson
  • Applicant: Henrik Bengtsson
  • Applicant Address: DK Bagsvaerd
  • Assignee: Novo Nordisk A/S
  • Current Assignee: Novo Nordisk A/S
  • Current Assignee Address: DK Bagsvaerd
  • Agent Wesley Nicolas
  • Priority: EP11160340 20110330
  • International Application: PCT/EP2012/055711 WO 20120329
  • International Announcement: WO2012/130992 WO 20121004
  • Main IPC: G06F19/00
  • IPC: G06F19/00 A61M5/24 A61B5/145 A61M5/31
System for optimizing a patient's drug dosage regimen over time
Abstract:
A system for optimizing a patient's basal insulin dosage regimen over time, adapted to (a) determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and (b) at the same time display blood glucose value data and the recommended amount data as a function of time.
Public/Granted literature
Information query
Patent Agency Ranking
0/0